REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

Walleye Capital LLC's Holding History (CIK: 0001758720)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 699,621 Value ($000) $3,631 Avg Close — Range —
Q2 2024
Shares 610,792 Value ($000) $1,570 Avg Close — Range —
Q1 2024
Shares 622,126 Value ($000) $3,061 Avg Close — Range —
Q4 2023
Shares 927,814 Value ($000) $8,155 Avg Close — Range —
Q3 2023
Shares 305,792 Value ($000) $3,507 Avg Close — Range —
Q2 2023
Shares 113,788 Value ($000) $2,880 Avg Close — Range —
Q1 2023
Shares 280,362 Value ($000) $9,030 Avg Close — Range —
Q4 2022
Shares 508,695 Value ($000) $9,391 Avg Close — Range —
Q3 2022
Shares 523,045 Value ($000) $14,122 Avg Close — Range —
Q2 2022
Shares 464,970 Value ($000) $6,426 Avg Close — Range —
Q1 2022
Shares 505,701 Value ($000) $9,861 Avg Close — Range —
Q4 2021
Shares 357,237 Value ($000) $5,830 Avg Close — Range —
Q3 2021
Shares 54,477 Value ($000) $1,518 Avg Close — Range —
Q2 2021
Shares 106,859 Value ($000) $3,167 Avg Close — Range —
Q1 2021
Shares 70,249 Value ($000) $1,963 Avg Close — Range —
Q4 2020
Shares 71,365 Value ($000) $2,022 Avg Close — Range —
Q3 2018
Shares 17,644 Value ($000) $438 Avg Close — Range —